v1
In vivo susceptibility of Mycobacterium ulcerans to KRM-1648, a new benzoxazinorifamycin, in comparison with rifampicin. Anti-mycobacterial activity of KRM-1648.
Identifier:nobleid.org/w1/20260515/AC8CB765
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/AC8CB765)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims
Paper Authors